ISEV
ISEV is the largest global non-profit professional society for extracellular vesicle researchers, serving 2,000+ members worldwide through two open-access journals, flagship annual meetings, and the MISEV research standardization guidelines.
- Company typePrivate
- Founded2011
- HeadquartersMount Royal, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What ISEV does
The International Society for Extracellular Vesicles (ISEV) is a non-profit professional scientific society founded in 2011 in Paris and now headquartered in Milwaukee, Wisconsin. It serves as the largest global community for extracellular vesicle (EV) researchers, with over 2,000 members across academia, clinical research, and industry. The society's mission centers on advancing EV research through standardization, education, and community building, addressing a fragmented field that historically lacked methodological uniformity.
ISEV's core offerings include two Gold Open Access journals published through Wiley: the Journal of Extracellular Vesicles (JEV, founded 2012) and the Journal of Extracellular Biology (JExBio, founded 2021), with article publishing charges of $4,200 and $3,100 respectively (members receive ~20-21% discounts). Its event portfolio comprises the flagship ISEV Annual Meeting (nearly 1,200 attendees in 2023), the technology-focused ISEVxTech workshop, EVClub journal discussions, and SNEV programming for early career researchers. Standardization efforts, led by the Scientific Reproducibility Subcommittee, produce the MISEV guidelines (2014, 2018, 2023), EV-TRACK transparency framework, and joint outputs with partner societies (ISAC, ISTH, ISCT, ELBS) and regulators (EMA, FDA).
Revenue is generated through four streams: membership dues (Junior $40/year, Senior $125/year, Community $40/year), journal article publishing charges, meeting and workshop registration fees, and tiered corporate sponsorship (Platinum/Gold/Silver/Bronze). The society operates as a member-funded 501(c)(3) equivalent with no parent company or outside equity ownership, governed by an elected Board of Directors. Customer segments include academic researchers and principal investigators (primary), early career researchers (primary), industry partners in biotech and pharma (secondary), and clinical/healthcare researchers (secondary), with global distribution across North America, Europe, Asia, and other regions.
ISEV firmographics
Firmographics- Name
- ISEV
- Legal name
- International Society for Extracellular Vesicles
- Website
- https://isev.org
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- ISEV is the largest global non-profit professional society for extracellular vesicle researchers, serving 2,000+ members worldwide through two open-access journals, flagship annual meetings, and the MISEV research standardization guidelines.
- Ownership category
- akta.pro rank
ISEV industry classification
Industry- Product category
- Scientific Professional Society and Academic Publishing
- NAICS
- Professional Organizations (81392), Business Associations (813910), Convention and Trade Show Organizers (56192), Professional, Scientific, and Technical Services (541)
- SIC
- Services-Membership Organizations (8600), Miscellaneous Publishing (2741), Services-Engineering, Accounting, Research, Management (8700)
- akta.pro primary industry
- Technical Committees, Working Groups & Expert Panels (BPADANAB)
Keywords
Where ISEV is headquartered
LocationHeadquarters
- HQ city
- Mount Royal
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
ISEV business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others
Revenue model
- Membership Dues: Annual and multi-year membership fees from junior, senior, and community members. Junior membership $40/year, Senior membership $125/year, with discounts for World Bank low-income countries and multi-year commitments.
- Journal Article Publishing Charges (APCs): ISEV operates two Gold Open Access journals (JEV and JExBio) published through Wiley. Standard APC for JEV is $4,200 (members pay $3,301); JExBio standard APC is $3,100 (members pay $2,480). Position Papers, Short Communications, and Technical Reports receive 50% discount.
- Meeting Registration Fees: Revenue from annual meetings, specialized workshops (ISEVxTech), and endorsed activities. Includes registration for ISEV2026 in Puerto Rico and various regional events.
- Sponsorship Revenue: Corporate sponsorship for annual meetings and events at various tiers (Platinum, Gold, Silver, Bronze). Sponsors include biotech and pharmaceutical companies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Junior Membership for students and researchers within 4 years of degree completion |
| Subscription | Annual | Senior Membership for established researchers, PIs, and post-docs |
| Subscription | Annual | Community Membership for basic participation |
| Freemium | Annual | SNEV ISEV Membership for Early Career Researchers |
| Other | Pay-as-you-go | Journal of Extracellular Vesicles (JEV) Article Publication Charge |
| Other | Pay-as-you-go | Journal of Extracellular Biology (JExBio) Article Publication Charge |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
ISEV product offering
Product offeringCore offering
ISEV is a non-profit scientific professional society that serves the global extracellular vesicle (EV) research community through membership-based access to two Gold Open Access journals, annual scientific meetings, specialized workshops, research standardization guidelines (MISEV), and community programs for early career researchers. The society provides discounted article publishing charges, reduced meeting registration, member directories, committee participation, and exclusive early-career resources through SNEV. Revenue is generated through membership dues, journal APCs, event registrations, and corporate sponsorships.
Product overview
ISEV is a professional society offering a portfolio of publications, events, and community services for the extracellular vesicle research community. The core offerings include two Gold Open Access journals (Journal of Extracellular Vesicles founded in 2012, and Journal of Extracellular Biology founded in 2021), flagship annual meetings and specialized events (ISEVxTech), community platforms (EVClub, SNEV for early career researchers, and Special Interest Groups), standardization guidelines (MISEV), and a career center job board. The society provides membership-based access to discounted publishing rates, meeting registration, and exclusive committee participation.
Differentiator
Problem solved
Functional benefit
Brands
- Journal of Extracellular Vesicles (JEV): The first journal of ISEV, founded in 2012, publishing open access research on extracellular vesicles.
- Journal of Extracellular Biology (J Ex Bio)
- MISEV
- SNEV
- ISEVxTech
Quantifiable outcome
- Standardization through MISEV guidelines improves research reproducibility across the EV field
- +2 more outcomes
Companies that use ISEV
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
ISEV technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
ISEV partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core, major and minor.
- Wiley (Journal Publishing)coreISEV partners with Wiley to publish its two flagship Gold Open Access journals: Journal of Extracellular Vesicles (JEV, founded 2012) and Journal of Extracellular Biology (JExBio, founded 2021). Wiley provides publishing infrastructure, distribution, and APC processing while ISEV maintains editorial governance and member discount programs.
- ISAC (International Society for Advancement of Cytometry)majorCollaboration through intersociety working groups on flow cytometry standards for extracellular vesicles. Joint publications include MIFlowCyt-EV framework and compendium of single EV flow cytometry.
- ISTH (International Society on Thrombosis and Haemostasis)majorJoint working groups on EV standardization, including flow cytometry standards and minimum information guidelines for extracellular vesicle research.
- ISCT (International Society for Cell and Gene Therapy)majorCollaboration on therapeutic applications of extracellular vesicles, joint statements on EVs from MSCs and other cells for potential COVID-19 treatments.
- European Liquid Biopsy Society (ELBS)minorCollaboration on liquid biopsy research and standardization efforts related to extracellular vesicles in clinical applications.
- EMA (European Medicines Agency) and FDA (U.S. Food and Drug Administration)majorCollaboration with regulatory agencies to develop guidance and standards for EV-based diagnostics and therapeutics, supporting translation from research to clinical applications.
- Global EV Network (National Societies)coreNetwork of national and regional EV societies worldwide including GEIVEX (Spain), Baltic Society for EVs, Turkish Community of EVs, American Society for Intercellular Communication, and others. ISEV endorses and coordinates with these societies on events and initiatives.
- Gordon Research ConferencesmajorISEV-endorsed Extracellular Vesicles Gordon Research Conference held in August 2026 (6-day event), bringing together global researchers for in-depth scientific discussions in a remote setting.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
ISEV competitors and assessment
Company assessmentBroad incumbents
- Federation of American Societies for Experimental Biology (FASEB): FASEB is a federation of multiple life-science societies that operates across many subfields, including publishing and policy advocacy; broader in scope than ISEV but uses a similar membership-and-publication-driven nonprofit model.
- American Chemical Society (ACS): ACS is a large established scientific society publishing dozens of journals and running major conferences; represents a broader-incumbent analog with overlapping publishing-and-events revenue mix but at vastly larger scale than ISEV.
Direct peers
- American Society of Gene & Cell Therapy (ASGCT): ASGCT is a US-based scientific professional society serving gene and cell therapy researchers with annual meetings, a flagship journal (Molecular Therapy), and member-driven standards — directly comparable to ISEV in mission, membership model, and event/publication portfolio, with overlapping EV-therapeutics research interests.
- International Society for Stem Cell Research (ISSCR): ISSCR is the global professional society for stem cell research, with an annual meeting, the journal Stem Cell Reports, and member-driven guidelines; closely comparable in size, structure, and EV-adjacent research interests.
- European Hematology Association (EHA): EHA is a Europe-based scientific society for hematology researchers with a large membership, annual congress, and journals; comparable to ISEV in governance, journal portfolio, and event-driven member value proposition.
- American Society for Cell Biology (ASCB): ASCB is a US-based scientific society serving cell biologists through meetings (Cell Bio), journals, and committee-driven advocacy; comparable to ISEV in its membership-funded nonprofit model, publication strategy, and conference-driven engagement.
- International Society for Cell & Gene Therapy (ISCT): ISCT is the global professional society for cell and gene therapy, operating an annual meeting, committee-driven standards, and a membership-funded model; it is an active ISEV partner (joint MSC-EV statements) and a near-twin in structure for a therapeutics-adjacent community.
- International Society for Advancement of Cytometry (ISAC): ISAC is a global scientific society for cytometry researchers, with membership dues, an annual congress, working groups, and joint publications (MIFlowCyt-EV with ISEV); structurally and operationally a direct peer serving a similarly sized specialized scientific community.
- Biophysical Society: Biophysical Society is a US-based nonprofit scientific membership organization with an annual meeting, member journal (Biophysical Journal), and committee-driven programs; matches ISEV's structure and member-publication-event model in a different but comparable niche.
- International Society on Thrombosis and Haemostasis (ISTH): ISTH is the global scientific society for thrombosis and haemostasis with a flagship journal (JTH), annual congress, and member-driven guideline initiatives; it is an active ISEV partner on flow-cytometry EV standards, with a comparable membership, journal, and standards model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
ISEV social profiles
Digital presenceISEV financial estimates
Financial estimateRevenue estimate
Valuation estimate
ISEV leadership team
Management profileNumber of profiles
Profiles6 records
ISEV funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ISEV M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ISEV
What does ISEV do?
ISEV is a non-profit scientific professional society that serves the global extracellular vesicle (EV) research community through membership-based access to two Gold Open Access journals, annual scientific meetings, specialized workshops, research standardization guidelines (MISEV), and community programs for early career researchers. The society provides discounted article publishing charges, reduced meeting registration, member directories, committee participation, and exclusive early-career resources through SNEV. Revenue is generated through membership dues, journal APCs, event registrations, and corporate sponsorships.
Is ISEV a public or private company?
ISEV is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was ISEV founded?
ISEV was founded in 2011. It employs 51 to 100 people.
Where is ISEV based?
ISEV is headquartered in Mount Royal, United States, in the North America region.
How does ISEV make money?
Four revenue lines are on record. Membership Dues are the primary driver. The others are journal Article Publishing Charges (APCs), meeting Registration Fees and sponsorship Revenue.
Who are ISEV's main competitors?
Broad incumbents on record are Federation of American Societies for Experimental Biology (FASEB) and American Chemical Society (ACS). Direct peers are American Society of Gene & Cell Therapy (ASGCT), International Society for Stem Cell Research (ISSCR), European Hematology Association (EHA), American Society for Cell Biology (ASCB), International Society for Cell & Gene Therapy (ISCT), International Society for Advancement of Cytometry (ISAC), Biophysical Society and International Society on Thrombosis and Haemostasis (ISTH).
Does ISEV have an API?
No public API is recorded for ISEV.
What industry is ISEV in?
ISEV's product category is Scientific Professional Society and Academic Publishing. Its primary akta.pro industry code is BPADANAB, Technical Committees, Working Groups & Expert Panels. Its NAICS code is 81392 and its SIC code is 8600.